Jump to Navigation

Facebook Connect

User login

Features' Archive

NLA Feature Stories Archive


No votes yet
Publish Date: 
Thursday, October 3, 2013 - 12:00

Join Us September 24 for FH Awareness Day and the 2016 Tweet-a-Thon!

This year, Familial Hypercholesterolemia (FH) Awareness Day is on September 24, 2016. It was initiated by The FH Foundation as part of their mission to raise awareness of FH in the public. The FH Foundation is a patient-... read more

Check Out the Latest Issue of LipidSpin

The National Lipid Association recently released its latest issue of LipidSpin – the 2016 Potpourri freelance edition. To download the issue and/or view the articles, visit lipid.org/lipidspin/all

NLA – Chief Science Officer Nominations Open

The National Lipid Association (NLA) is seeking nominations for the Chief Science Officer (CSO) position for the 2017-2020 term, beginning at the 2017 NLA annual Scientific Sessions and ending at the conclusion of the 2020 annual Scientific Sessions.  The nomination requirements... read more

Foundation to Launch Rare Disease Campaign in Conjunction with National Cholesterol Education Month

The Foundation of the National Lipid Association, in conjunction with National Cholesterol Education Month, will launch the RADAR Campaign (RADAR: RAre Disease AwaReness) providing resources and tools to both patients and healthcare professionals designed to help improve the identification and... read more

Challenges in Prescribing PCSK9 Inhibitors Survey

The National Lipid Association (NLA) is committed to enhancing the practice of lipid management in clinical medicine. A major component is having access to all therapies to properly treat patients with the management of lipid disorders. PCSK9 inhibitors are one therapy that patients have... read more

Statin-Related Muscle Symptoms More Common in Patients With Metabolic Syndrome

A new study shows that muscle pain and weakness, already common enough in patients taking statins -- the most widely used cholesterol-lowering medications -- appear to be even more common in patients with metabolic syndrome (MetSynd). In a scientific publication in the Journal of Clinical... read more

2016 Fall CLU Meeting Coverage

The National Lipid Association has featured highlights from selected presentations at the 2016 Clinical Lipid Update in Amelia Island. Read our meeting coverage here.

Don’t Miss 'The Provider’s Approach to PCSK9 Antibodies' CME/CE Dinner Symposium

In order to bring further insight and understanding surrounding PCSK9 antibodies and their use in clinical practice, the NLA will host an in-depth supplemental symposium to be held in conjunction with the NLA 2016 Fall Clinical Lipid Update. This 2-hour symposium, held Friday, August 26 from 6:... read more

ICD-10 Codes for Familial Hypercholesterolemia (FH) Approved

The new ICD-10 Codes were released by the Center for Medicare & Medicaid Services (CMS). Two new specific codes for FH have been approved:

  • E78.01: Familial hypercholesterolemia
  • Z83.42: Family history of familial hypercholesterolemia

The National Lipid... read more

Journal of Clinical Lipidology Sees Another Increase in Impact Factor

The 2015 Impact Factors were recently released and the Journal of Clinical Lipidology (JCL) saw yet another significant increase — from 3.904 (2014) to 4.906 (2015). The Journal is now ranked 23rd out of 253 journals in its category (pharmacology and pharmacy). The Thomson-Reuters... read more


by Dr. Radut.